These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 524688)
1. [Peripheral macro-and microcirculatory changes in acute arterial obstruction with papaverine and trental administration]. Koshkin VM; Adil'khanov SG; Antonova NIu Vestn Khir Im I I Grek; 1979 Dec; 123(12):56-60. PubMed ID: 524688 [TBL] [Abstract][Full Text] [Related]
2. [Some mechanisms of papaverine and trental action in patients with acute arterial obstruction]. Sergeeva NA; Terekhova TV; Koshkin VM; Adil'khanov SG; Sapozhnikov VA Vestn Khir Im I I Grek; 1980 May; 124(5):10-3. PubMed ID: 6252675 [TBL] [Abstract][Full Text] [Related]
3. [Correction of disorders of peripheral circulation with trental in children in the postoperative period]. Doletskiĭ AS; Dallakian NO; Aksel'rov AM; Nazarova NB; Sokolova VA Anesteziol Reanimatol; 1985; (4):56-8. PubMed ID: 4061952 [No Abstract] [Full Text] [Related]
4. [Effect of papaverine and trental on hemostasis and rheologic properties of blood in acute arterial obstruction]. Zatevakhin II; Koshkin VM; Shestakov VA; Il'in SG; Adil'khanov SG Probl Gematol Pereliv Krovi; 1979 Dec; 24(12):40-3. PubMed ID: 523450 [No Abstract] [Full Text] [Related]
5. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease. Chopra HK; Chopra KL; Aggarwal KK; Parashar SK J Med; 1988; 19(2):89-107. PubMed ID: 3049876 [TBL] [Abstract][Full Text] [Related]
6. [Effectiveness of intravenous infusion treatment of peripheral arterial occlusive disease with Trental--results of a multicenter double-blind study]. Rudofsky G; Haussler KF; Künkel HP; Schneider-May H; Spengel F; Symann O; Werner HJ; Rössner M Vasa Suppl; 1987; 20():375-8. PubMed ID: 3321494 [No Abstract] [Full Text] [Related]
7. Effects of pentoxifylline and papaverine on tissue perfusion during arterial surgery. Niinikoski J; Vänttinen E Acta Chir Scand; 1988; 154(11-12):641-5. PubMed ID: 3232482 [TBL] [Abstract][Full Text] [Related]
8. [Clinical trial of Trental 100 in patients with peripheral arterial occlusive diseases (author's transl)]. von Westphalen JG MMW Munch Med Wochenschr; 1977 Jul; 119(26):901-4. PubMed ID: 408616 [TBL] [Abstract][Full Text] [Related]
9. [Drug therapy of arterial diseases. A study with Trental 400]. Tannenberg G Fortschr Med; 1980 Dec; 98(45):1795-8. PubMed ID: 7461576 [TBL] [Abstract][Full Text] [Related]
10. [Basic mechanisms of the action of trental (pentoxifylline) on the microcirculation)]. Vinnitskiĭ LI Patol Fiziol Eksp Ter; 1979; (6):69-70. PubMed ID: 232259 [No Abstract] [Full Text] [Related]
11. Pentoxifylline -- a biomedical profile. Müller R J Med; 1979; 10(5):307-29. PubMed ID: 393789 [TBL] [Abstract][Full Text] [Related]
12. [Trental treatment of microcirculatory disorders in diabetes mellitus and arteriosclerosis]. Vogralik VG; Vogralik MV; Runov GP; Runova AA; Kostrov AI Klin Med (Mosk); 1982 Oct; 60(10):90-4. PubMed ID: 7176484 [No Abstract] [Full Text] [Related]
13. [Treatment of chronic arterial occlusive disease. Clinical study with a new galenic preparation of Pentoxifyllin (Trental 400) (author's transl)]. Angelkort B; Doppelfeld E Med Klin; 1978 May; 73(21):791-7. PubMed ID: 651768 [TBL] [Abstract][Full Text] [Related]
14. [Effect of a course of pentoxifylline (trental) treatment on microcirculatory and central hemodynamic functions in chronic ischemic heart disease patients]. Atroshchenko ES Ter Arkh; 1985; 57(1):43-6. PubMed ID: 3983842 [TBL] [Abstract][Full Text] [Related]
15. [Assessment of the therapeutic effect of Trental 400. Double-blind study in geriatric patients with circulatory disorders]. Feine-Haake G Fortschr Med; 1977 Jan; 95(1):48-51. PubMed ID: 401759 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of arterial diseases with trental 400. Results of a double-blind study]. Völker D Med Welt; 1978 Aug; 29(32):1244-7. PubMed ID: 672594 [No Abstract] [Full Text] [Related]
17. [Treatment of circulation disorders with pentoxifylline. A double-blind study with Trental]. Tonak J; Knecht H; Groitl H Med Monatsschr; 1977 Oct; 31(10):467-72. PubMed ID: 337089 [No Abstract] [Full Text] [Related]
18. Treatment of chronic occlusive arterial disease with pentoxifylline: changes in clinical and haemodynamic parameters. Schweiger H; Ortmeier CJ Pharmatherapeutica; 1989; 5(5):298-304. PubMed ID: 2526340 [TBL] [Abstract][Full Text] [Related]
19. The effect of pentoxifylline on the deformability of erythrocytes and on the muscular oxygen pressure in patients with chronic arterial disease. Ehrly AM J Med; 1979; 10(5):331-8. PubMed ID: 294470 [No Abstract] [Full Text] [Related]
20. [Clinical pharmacology of vasoactive substances: study on pentoxifylline]. Pupita F; Rotatori P; Frausini G Ric Clin Lab; 1981; 11 Suppl 1():293-302. PubMed ID: 7188116 [No Abstract] [Full Text] [Related] [Next] [New Search]